Hui et al. reported similar findings about adipokines (adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor-21) in the pathophysiology of NAFLD and diabetes [34]. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatotic liver disease.